[1]周敏,魏秋霞,林俊杰,等.良恶性肿瘤18F-FDG符合线路显像的临床价值[J].国际放射医学核医学杂志,2011,35(5):279-281.[doi:10.3760/cma.j.issn.1673-4114.2011.05.006]
　ZHOU Min,WEI Qiu-xia,LIN Jun-jie,et al.18F-FDG coincidence imaging for the detection of benign and malignant neoplasm[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(5):279-281.[doi:10.3760/cma.j.issn.1673-4114.2011.05.006]
点击复制

良恶性肿瘤18F-FDG符合线路显像的临床价值(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
35
期数:
2011年第5期
页码:
279-281
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
18F-FDG coincidence imaging for the detection of benign and malignant neoplasm
作者:
周敏;  魏秋霞;  林俊杰;  陈丽丽
福建省莆田市第一医院核医学科, 福建 351100
Author(s):
ZHOU Min;  WEI Qiu-xia;  LIN Jun-jie;  CHEN Li-li
Department of Nuclear Medicine, Putian First Hospital of Fujian Province, Fujian Putian 351100, China
关键词:
肿瘤; 氟脱氧葡萄糖F18; 体层摄影术; 发射型计算机; 单光子
Keywords:
Neoplasms; Fluorodeoxyglucose F18; Tomography; emission-computed; single-photon
DOI:
10.3760/cma.j.issn.1673-4114.2011.05.006
摘要:
目的 评价18F-FDG符合线路显像检测良恶性肿瘤的诊断价值。方法 回顾性分析135例病变性质不明患者的18F-FDG符合线路显像结果,并与常规影像学检查结果进行对比分析。病变的确诊依据手术病理检查和临床随诊。结果 135例患者经病理学检查及随访结果最终确诊为恶性病变者86例(病灶数:95个),良性病变者49例(病灶数:53个)。恶性病变中,18F-FDG检查病灶数较常规影像学检查增多38个,而病灶数减少的仅有8个。18F-FDG符合线路显像诊断恶性肿瘤的灵敏度、特异度和准确率分别为:90.7%(78/86)、87.8%(43/49)和89.6%(121/135).结论 18F-FDG符合线路显像能更灵敏、准确地检出良恶性肿瘤,可为患者选择治疗方案提供可靠的依据。
Abstract:
Objective To evaluate 18F-FDG coincidence imaging for the detection of benign and malignant tumor diagnosis. Methods Retrospectively analyzing 135 18F-FDG dual head coincidence imaging results whose patients had unknown lesions, and comparing with conventional radiographic examination results. The diagnosis of lesion is based on surgical pathology and clinical follow-up. Results Eighty-six of all the 135 patients were diagnosed as malignant lesions(of 95 niduses), 49 of all the cases were benign lesion(of 53 niduses). 18F-FDG coincidence imaging detected 38 more niduses than conventional radiographic examination, where the niduses reduced by only eight. The sensitivity, specificity and accuracy of the 18F-FDG coincidence imaging in diagnosing carcinoma were 90.7%(78/86), 87.8%(43/49) and 89.6%(121/135). Conclusion 18F-FDG coincidence imaging is more sensitive, accurate in detecting benign and malignant tumor, and helps to clinical diagnosing and selecting patients to provide reliable basis for treatment options.

参考文献/References:

[1] Bar-shalom R,Valdivia AY,Blaufox MD.PET imaging in oncology.Semin Nucl Med,2000,30(3):150-185.
[2] Phelps ME.PET:the merging of biology and imaging into molecular imaging.J Nucl Med,2000,41(4):661-681.
[3] Shreve PD,Steventon RS,Deters EC,et al.Oncologic diagnosis with 2-[fluorine-18] fluoro-2-deoxy-D-glucose imaging:dual-head coincidence gamma camera versus positron emission tomo-graphic scanner.Radiology,1998,207(2):431-437.
[4] Kam BL,Valkema R,Poldermans D,et al.Feasibility and image quality of dual-isotope SPECT using 18F-FDG and 99mTc-tetrofosmin after acipimox administration.J Nucl Med,2003,44(2):140-145.

相似文献/References:

[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
　He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
　Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
　Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[4]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
　Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[5]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
　Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[6]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
　You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[7]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
　Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[8]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
　Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
[9]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
　zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[10]许靖,李肖红,秦永德,等.帕金森病脑部葡萄糖代谢和脑多巴胺转运体PET显像特点的临床研究[J].国际放射医学核医学杂志,2016,40(5):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
　Xu Jing,Li Xiaohong,Qin Yongde,et al.Clinical study of brain glucose metabolism and brain dopamine transporter PET imaging in patients with Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
[11]刘春利,李毅红.18F-FDG PET/CT在原发灶不明的脑转移瘤中的诊断价值[J].国际放射医学核医学杂志,2013,37(2):92.[doi:10.3760/cma.j.issn.1673-4114.2013.02.008]
　LIU Chun-li,LI Yi-hong.The value of 18F-FDG PET/CT in diagnosing brain metastases from unknown primary tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):92.[doi:10.3760/cma.j.issn.1673-4114.2013.02.008]
[12]王胜军,杨卫东,赵小虎,等.18F-FDG PET/CT诊断多发癌的价值[J].国际放射医学核医学杂志,2013,37(2):96.[doi:10.3760/cma.j.issn.1673-4114.2013.02.009]
　WANG Sheng-jun,YANG Wei-dong,ZHAO Xiao-hu,et al.Value of 18F-FDG PET/CT in the diagnosis of multiple primary malignant neoplasms[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):96.[doi:10.3760/cma.j.issn.1673-4114.2013.02.009]
[13]王玉婷,黄钢,蒋瑾,等.18F-FDG PET用于肿瘤治疗疗效评价的meta分析进展[J].国际放射医学核医学杂志,2012,36(6):334.[doi:10.3760/cma.j.issn.1673-4114.2012.06.004]
　WANG Yu-ting,HUANG Gang,JIANG Jin,et al.Tumor response monitoring by 18F-FDG PET: updated review of meta-analyses[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(5):334.[doi:10.3760/cma.j.issn.1673-4114.2012.06.004]
[14]江茂情,吴华.18F-FDG和18F-FLT PET-CT在肿瘤非手术治疗早期疗效评价中的应用[J].国际放射医学核医学杂志,2012,36(6):339.[doi:10.3760/cma.j.issn.1673-4114.2012.06.005]
　JIANG Mao-qing,WU Hua.18F-FDG and 18F-FLT PET-CT in evaluation of the early response of malignant tumors after different therapies[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(5):339.[doi:10.3760/cma.j.issn.1673-4114.2012.06.005]
[15]江茂情,吴华.18F-FDG和18F-FLTPET对肿瘤放化疗疗效评价的实验研究[J].国际放射医学核医学杂志,2011,35(3):146.[doi:10.3760/cma.j.issn.1673-4114.2011.03.004]
　JIANG Mao-qing,WU Hua.The experimental study on 18F-FDG and 18F-FLT PET in assessing the outcome of cancer chemotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(5):146.[doi:10.3760/cma.j.issn.1673-4114.2011.03.004]
[16]张慧玮,赵军.18F-FDG代谢显像相关分子机制的研究进展[J].国际放射医学核医学杂志,2011,35(1):1.[doi:10.3760/cma.j.issn.1673-4114.2011.01.001]
　ZHANG Hui-wei,ZHAO Jun.Progress of molecular mechanism of 18F-FDG metabolism imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(5):1.[doi:10.3760/cma.j.issn.1673-4114.2011.01.001]
[17]李亚军,张慧娟.放射性核素标记胆碱与18F-FDG PET肿瘤显像的对比研究[J].国际放射医学核医学杂志,2010,34(6):348.[doi:10.3760/cma.j.issn.1673-4114,2010.06.007]
　LI Ya-jun,ZHANG Hui-juan.Comparison choline with 18F-FDG PET in various tumors imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(5):348.[doi:10.3760/cma.j.issn.1673-4114,2010.06.007]
[18]李红梅,冯珏,李晓东,等.18F-FLT对恶性肿瘤治疗效果的评估价值[J].国际放射医学核医学杂志,2009,33(3):136.[doi:10.3760/cma.j.issn.1673-4114.2009.03.003]
　LI Hong-mei,FENG Jue,LI Xiao-dong,et al.The value of 18F-fluorothymidine to monitor the therapeutic effect of malignant tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(5):136.[doi:10.3760/cma.j.issn.1673-4114.2009.03.003]
[19]司宏伟,徐慧琴,岳峤,等.肿瘤组织乏氧与葡萄糖代谢[J].国际放射医学核医学杂志,2009,33(4):200.[doi:10.3760/cma.j.issn.1673-4114.2009.04.003]
　SI Hong-wei,XU Hui-qin,YUE Qiao,et al.Hypoxia and glycometabolism in cancer tissue[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(5):200.[doi:10.3760/cma.j.issn.1673-4114.2009.04.003]
[20]陈香,赵晋华.PET及PET-CT在监测肿瘤治疗效果中的价值[J].国际放射医学核医学杂志,2007,31(6):354.
　CHEN Xiang,ZHAO Jin-hua.Value of PET and PET-CT for monitoring tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(5):354.

备注/Memo

备注/Memo:
收稿日期:2011-06-25。
通讯作者:周敏(Email:13559398955@139.com)
更新日期/Last Update: 1900-01-01